Ventriculoperitoneal shunt surgery and shunt infections in children with non-tumour hydrocephalus at the Kenyatta National Hospital, Nairobi by Mwang'ombe, NJM & Omulo, T
386 EAST AFRICAN MEDICAL JOURNAL July 2000
East African Medical Journal Vol. 77 No. 7 July 2000
VENTRICULOPERITONEAL SHUNT SURGERY AND SHUNT INFECTIONS IN CHILDREN WITH NON-TUMOUR HYDROCEPHALUS AT THE KENYATTA
NATIONAL HOSPITAL, NAIROBI
N.J.M. Mwang’ombe, MMed, PhD (Lond), Senior Lecturer  and T. Omulo, MBChB, MMed, Lecturer, Department of Surgery, College of Health Sciences, University of
Nairobi. P.O. Box 19676, Nairobi, Kenya
Request for reprints to: Dr. N.J.M. Mwang’ombe,  Department of Surgery, College of Health Sciences, University of Nairobi. P.O. Box 19676, Nairobi, Kenya
VENTRICULOPERITONEAL SHUNT SURGERY AND SHUNT INFECTIONS IN CHILDREN WITH
NON-TUMOUR HYDROCEPHALUS AT THE KENYATTA NATIONAL HOSPITAL, NAIROBI.
N.J.M. MWANG’OMBE and T. OMULO
ABSTRACT
Objective: To study infections complicating ventriculoperitoneal (VP) shunt surgery in
children with non-tumour hydrocephalus at the Kenyatta National Hospital, Nairobi.
Design: A retrospective survey.
Setting: Kenyatta National Hospital, Nairobi between January 1982 and December 1991.
Subjects: Three hundred and forty five patients who underwent V-P shunt placement for
non-tumour hydrocephalus.
Results: Three hundred and forty five patients underwent V-P shunt placement for non-
tumour hydrocephalus. There were 107 infection episodes involving 85 patients. The ages of
these patients ranged from three months to 12 years. Most of the patients had congenital
hydrocephalus. The infection rate was high (24.6%) although comparable to infection rates
reported for clean surgery in the hospital. Fever, septic wounds and features of shunt
malfunction were the main presenting features. Bacteriological studies confirmed
Staphylococcus aureus and coagulase negative staphylococci as the two most commonly
isolated micro-organisms.
Conclusion: This study emphasises need to reduce infection rate in ventriculoperitoneal
shunt surgery at the Kenyatta National Hospital. Definitive surgical treatment for
hydrocephalus was in most cases delayed and this problem was also observed during revision
of infected shunts. Late presentation was often due to ignorance and the fact that many
patients went for traditional forms of treatment first before going to hospital.
INTRODUCTION
Hydrocephalus may be defined as the excess
accumulation of cerebrospinal fluid within the cerebral
ventricles due to a disturbance of its secretion, flow or
absorption. Cerebrospinal fluid (CSF) is produced by the
choroid plexus of the two lateral, the third and fourth
ventricles though some may be formed on the surface of
the brain and spinal cord (1). CSF circulates through the
ventricles and subarachnoid space that surround both the
brain and spinal cord. The two lateral ventricles
communicate with the third ventricles through the foramina
of Monro, which communicates with the fourth ventricles
by means of the aqueduct of Sylvius. The CSF reaches the
basal cisterns and subarachnoid space from the fourth
ventricle through the lateral foramina of Luschka and
foramen of Magendie. From these basal cisterns, CSF
migrates over the convexities toward the cerebral sinuses
where it is re absorbed into circulation by the arachnoid
villi (1,2).
Hydrocephalus may result from congenital or acquired
causes which may disturb its secretion (for example:
choroid plexus papilloma), its flow or its absorption.
Hydrocephalus has also been classified as obstructive or
non- obstructive. Obstructive hydrocephalus occurs where
there is a block to the flow of CSF. Non-obstructive
hydrocephalus occurs where there is free flow of the CSF
along its pathway from the ventricles to the absorption
area by arachnoid villi.
Hydrocephalus in children, if untreated, causes
developmental disorders, mental deficiencies and
shortened life expectancy in addition to blindness and
other neurological deficits as a result of cerebral injury
due to distention of brain tissue (3).
In this paper the results of a ten year retrospective
study done to review the problem of V-P shunt infection
at Kenyatta National Hospital between 1982 and 1991
are presented.
MATERIALS AND METHODS
This is a ten-year retrospective study from January 1982 to
December 1991. The study includes patients aged one day old
to 12 years managed for ventriculoperitoneal shunt infections
at Kenyatta National Hospital. Patients with shunts for
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Figure 1
Time interval from onset of hydrocephalus to first shunt surgery
The causes of hydrocephalus were congenital in 77.6%
of the patients and acquired in 22.4%. Twenty seven
patients (31.8%) underwent shunt revisions for other
reasons before they presented with shunt infection while
58 patients (68.2%) had not undergone any previous shunt
revisions. Eighteen of the patients had one shunt revision
each, seven had two shunt revisions each, and two had
three shunt revisions each giving a total of 38 shunt
revisions. There were various reasons for these shunt
revisions(Table 1) but shunt block was the most common
reason.
Other local or systemic infections were observed in
21.3% of patients with V-P shunt infection. Thirteen
patients were found to be anaemic and malnourished.
Most of the infection episodes (83 out of the 107 episodes)
presented within four months from the time of the last
surgical procedure. Twenty of the infection episodes
occurred between five and twenty months and only four
infection episodes occurred after two years from the time
of the last surgical procedure.
Fever, irritability and vomiting were the most common
symptoms in patients who developed shunt infection.
Fever was observed in 86 infection episodes. Irritability
and vomiting were each found in 63 infection episodes.
Other features observed were convulsions, lethargy,
anorexia, dehydration and diarrhoea.
Thirty seven of the 107 infection episodes (34.6%)
were not associated with any wound at the site of previous
shunt surgery while 70 infection episodes (65.4%) had
septic wounds. Of those with septic wounds, 59.3% had
infections involving the abdominal wall, 26.7% were on
the scalp, and 14.0% were found at other sites along the
shunt tract. Features of shunt tract inflammation
characterised by presence of redness and/or tenderness
along the shunt tract were observed in 33 of the 107
infection episodes (Table 2). The shunt was found exposed
in the wound in 25 of the 107 infection episodes. CSF leak
through the wound was observed in 28 of the 107 infection
hydrocephalus due to tumours were excluded. The relevant data
was obtained from the patients case notes in the hospital records
department.
RESULTS
Three hundred and forty five patients underwent V-P
shunt placement at Kenyatta National Hospital between
January 1982 and December 1991. Eighty five of these
patients developed VP shunt infections (24.6% infection
rate).
It was noted that some patients presented more than
once during this period with what was seen to be different
infections (initial infection having been considered treated).
The majority of patients (78.8%), however had only one
infection episode each. Fourteen patients (16.5%) presented
two times with infection and four patients (4.7%) presented
three times. Therefore, there were 107 infection episodes
involving 85 patients during that ten-year period (Table
1). There were forty eight male patients (56.5%) and 37
female patients (43.5%) giving a male: female ratio of
1.3:1.
The youngest patient was three months old and the
oldest twelve years. Majority of the patients were below
one year of age (50.6%) as shown in Table 1. There was a
considerable delay from the time the patient was diagnosed
to have hydrocephalus to the time of placement of a VP
shunt. This time interval was less than three months in
43.5% of the patients (Fig. 1). The delay encountered in
placement of VP shunt was usually due to unwillingness
of parents of the patients to have a V-P shunt inserted or
inability to afford the shunt.
Table 1
Pre-infection shunt revisions, age distribution in shunt infections and
frequency of infection episodes
Frequency % Total
Shunt block 20 52.6
Shunt 5 13.2
migration





Age distribution Less than 43 50.6
in shunt infections one year
1- 2 years 27 32.7 85(100%)
3-6years 8 9.4
7-12 years 7 8.3
Number of infection       1 67 78.8 85(100%)
episodes per patient      2 14 (28) 16.5 (107
       3 4 (12) 4.7 episodes)
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negative staphylococci (the next commonest isolate) was
found sensitive to chloramphenicol (75%), penicillin
(66.7%) and amoxycillin (75%).
Several management options were applied in treating
patients with shunt infection. In 64 of the 107 infection
episodes, the infected shunts were removed and reinsertion
of a shunt done at a later date after the infection was
treated. The time interval between removal of an infected
shunt and reinsertion of new shunt varied between seven
days and four weeks. In thirty out of the 107 infection
episodes, the shunts were not removed but the patients
were treated with systemic antibiotics. In five out of the
107 infection episodes, the shunts were removed and a
new shunt inserted at the same sitting on the opposite side.
In seven of the 107 infection episodes new shunts were
inserted on opposite side with the old shunt still in place
and the patients treated with systemic antibiotics The old
shunts were removed at a later date, usually on the tenth
day, after removal of stitches. Externalisation of distal end
of shunt with CSF drainage into a closed system was done
in one infection episode where there was ventriculitis. A
new shunt was inserted on the opposite side after the
infection had subsided.
DISCUSSION
In this study, 107 infections were observed in 85
children with ventriculoperitoneal shunts for non tumour
hydrocephalus between 1982 and 1991 at the Kenyatta
National Hospital. Three hundred and forty five patients
underwent V-P shunt placement for non-tumour
hydrocephalus at the Kenyatta National Hospital during
that period. The infection rate observed for V-P shunt
placement was 24.6%. This infection rate is high when
compared with figures reported from centres in the Western
World. However, it falls within the wide range of 0.0-
38.0% that has been reported in the literature (4). A study
carried out on post-operative wound infections at the
Kenyatta National Hospital(5) found an infection rate of
26.3% complicating clean elective general surgical
procedures, a rate which, although high is similar to the
one reported in this study.
The relatively high rate of infection seen in patients
undergoing V-P shunt surgery at the Kenyatta National
Hospital may be related to hospital or theatre environment
since a similar high rate of infection was reported in a
previous study at the same institution on patients
undergoing elective surgery (5). This high rate of infection
is also similar to other rates of post surgical infection
reported from other developing countries (5,6).
Other factors which may contribute to the high rate of
infection may be patient-related (for example, poor
nutritional status, other concurrent infections). They may
also be surgeon and theatre related. The relatively long
ward-waiting time that most of the patients experienced
before operation may also play a role in the high infection
rate (5). This long pre-operative stay in the ward was due
episodes whereas swelling and cyst (or pseudocyst)
formations along the shunt tract in form of subcutaneous
CSF collections were seen in 35 infection episodes
 (Table 2).
Table 2
Signs and symptoms associated with shunt infections.










Inflammation along shunt tract 33
Exposed shunt 25
Swelling and cysts along shunt 35
Tract
CSF leaks 28
Signs of shunt block such as tense or bulging anterior
fontanelle, progressive enlargement of the head, vomiting
and convulsions were seen in 23 of the 107 infection
episodes (21.5%). Features suggestive of  meningitis,
such as neck stiffness and positive Kernig, were seen in 20
of the 107 infection episodes (18.7%), while ventriculitis
was found in three infection episodes (2.8%) and peritonitis
in eleven infection episodes (10.3%).
Fifty six of the 107 infection episodes had
bacteriological studies such as wound swabs, CSF culture
and V-P shunt system culture done to determine culture
and sensitivity pattern of the organisms. There were 43
wound swabs processed out of which 34 had bacteria
isolated (79.1%). There were 29 CSF specimen processed,
out of which eight were positive (27.6%). Eight removed
V-P shunts were sent for culture and six grew organisms
(75.0%).
The spectrum of bacterial isolates and their source
was also analysed. Staphylococcus aureus was the most
commonly isolated microorganism (27 isolates) forming
48.2% of the total isolates. Coagulase negative
staphylococci were the next most common isolates (nine
isolates) forming 16.1% of the total isolates. Escherichia
coli and citrobacter species were found in 7.1% of the total
isolates (four isolates each). The other bacteria isolated
were Klebsiella species (three), Acinetobacter (two),
Pseudomonas species (two), Streptococcus faecalis (two),
Salmonella typhimurium (one), Proteus species (one), and
alpha-haemolytic streptococci (one).
Staphylococcus aureus was found to be sensitive to
chloramphenicol (88.9%), methicillin (75%), erythromycin
(73.7%) and lincomycin (86.7%) . Sensitivity was low to
some commonly used antibiotics such as penicillin (13.3%),
cotrimoxazole (50%) and ampicillin (26.7%). Coagulase
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to factors such as a large patient work load, inability by the
patient to afford a shunt immediately, unavailability of
materials necessary for surgery and other similar problems
found in the developing world. The male to female ratio of
1.3 :1 observed in this study is probably a reflection of the
general trend of male predominance in children with
hydrocephalus undergoing shunt surgery (4,6-9).
The ages of the children in this study at the time of
presentation with vetriculoperitoneal shunt infection are
seen to range from three months to twelve years. The
majority of the children were between three months and
three years of age (82.4%). This may be due to the fact, that
most of the children had hydrocephalus due to congenital
causes. Studies done by other workers elsewhere show a
similar pattern (4,7,10,11). James(7), reported an age
range of two months to 7.5 years in his patients with CSF
shunt infections, while Quigley reported an age range of
three months to 10 years with most of the patients being
under one year(4). In this study most of the patients had
shunts inserted at the age of less than one year with a peak
age for shunt insertion at 3-4 months. This pattern is
similar to that seen in other studies (4,8) although in Puri’s
study (8) the peak age for shunt insertion was a little earlier
at age two to three months.
The time interval from the onset of hydrocephalus or
diagnosis of hydrocephalus to first shunt placement appears
to be little reported in the literature. This time interval is of
interest because it has a bearing on the neurological status
of the child or brain damage that may occur before shunt
surgery. Most of the patients in this study were found to
have experienced a considerable delay before they could
have shunt placement surgery. The delays were due to a
number of reasons ranging from non-availability of shunts
(patient’s family unable to buy shunt) to the large number
of patients awaiting surgery in the unit.
Although this study did not address the risk of
developing shunt infection in relation to aetiology of
hydrocephalus, other workers elsewhere have discussed
this issue. Most workers have found no association between
aetiology of hydrocephalus and shunt infection (9,11-15).
Some have however found myelomeningocele to be a risk
factor (16-18) while others have found intraventricular
haemorrhage as a cause of hydrocephalus to be a major
risk factor in shunt infection (4). Various reasons were
given for the shunt revisions undertaken in this study prior
to the development of shunt infection. Shunt block was the
most common reason for shunt revision. Shunt blocks,
which are a form of shunt malfunction, have been noted to
be probably related to shunt infection in some
studies(6,10,22).
The role of other concurrent infections elsewhere in
the body before or at the time of shunt surgery was
reviewed by Renier (13) who found an association between
the risk of shunt infection and upper respiratory tract
infections. Concurrent infections were reported in 21.3%
of patients presenting with infected V-P shunts in this
study. However, other workers have found no correlation
between the risk of shunt infection and other concurrent
infections at the time of shunt surgery(4,12,14,18).
Anaemia and malnutrition reported in 13 of our patients
(15.3%) may have predisposed to infection by impairing
the patients ability to resist infections. The highest bacterial
isolation rate per type of specimen was from wound
cultures (pus swabs). This is probably a reflection of the
fact that cultures were done when there were obvious
features of wound infection. A similar observation was
made by Schoenbaum (11) who found 100% isolation rate
from wound cultures. Removed shunts also showed a high
isolation rate in this study. The low CSF bacterial isolation
rate of 27.6% observed in this study is in sharp contrast to
the CSF isolation rate of Schoenbaum(11) of 79%.
Staphylococcus aureus was the commonest organism
isolated followed by coagulase negative staphylococci.
This may be related to the fact that most of our isolates
were from wounds. Bayston(19,20,22) has observed that
Staphylococcus aureus involvement in shunt infections
appears to be more common in some units than others and
their presence may be related to wound infections around
the shunt rather than true shunt colonisation. Most of the
infections in this study (71%) were managed by removal
of the infected shunt and placement of a new shunt. The
practice of removal of an infected shunt followed by
immediate shunt replacement at the same sitting has been
tried by some workers(7,21,23) with good results. However,
when these results are compared with those where a shunt
is reinserted after a period of treatment with antibiotics to
control infection, the later option is found to be superior.
This period of antibiotic therapy before shunt reinsertion
is seen to be necessary to eradicate bacteria from the
ventricles and peritoneal cavity(22). Bayston has
recommended reinsertion of new shunts after a period of
five and ten days of antibiotic therapy(22).
The difficulties in making diagnosis of shunt infection,
and hence delayed shunt removal, has also been mentioned
by Bayston(22). James(7) recommended reinsertion of a
shunt after seven days of antibiotic therapy in patients who
had their infected shunts removed. Many of the patients in
this study experienced a delay before shunt reinsertion due
to presence of infected wounds which took a long time to
heal. Other reasons similar to those cited for initial shunt
insertions like non availability of shunts also played a role
in this delay. In conclusion, it has been observed in this
study that the rate of infection in children undergoing
ventriculoperitoneal shunt placement for hydrocephalus at
the Kenyatta National Hospital was rather high. This high
rate may be related to the surgical technique and theatre
conditions at the time of surgery in addition to other patient
related factors, such as, malnutrition, anaemia and prolonged
pre-operative waiting period in the ward which would allow
colonisation with hospital flora. The prolonged ward-waiting
period may be due to theatre related factors and surgeon-
related factors.
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